Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2018-02-21

FDA Approved: VOLTAREN ARTHRITIS PAIN — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

The FDA approved a supplemental application to Voltaren Arthritis Pain to update the product’s labeling for arthritis pain relief with diclofenac sodium topical…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Voltaren Arthritis Pain (Diclofenac sodium)

Snippet

SUPPL AP for VOLTAREN ARTHRITIS PAIN (DICLOFENAC SODIUM)